Håvard Selby Ebbestad
Amministratore Delegato presso Dr. Fürst Medisinsk Laboratorium AS
Profilo
Håvard Selby Ebbestad is currently the Managing Director at Dr. Fürst Medisinsk Laboratorium AS and Director at Sens Utvikling AS.
Previously, he worked as the Chairman at Legemiddelindustriforeningen from 2007 to 2009, Managing Director at AstraZeneca AS, Director at Lytix Biopharma AS, and Managing Director at Pfizer AS.
He holds graduate degrees from McGill University and the University of Oslo.
Posizioni attive di Håvard Selby Ebbestad
| Società | Posizione | Inizio |
|---|---|---|
Dr. Fürst Medisinsk Laboratorium AS
 Dr. Fürst Medisinsk Laboratorium AS Medical/Nursing ServicesHealth Services Dr. Fürst Medisinsk Laboratorium AS operates as a medical laboratory in the fields of medical biochemistry, clinical pharmacology, microbiology, and pathology. The firm provides medical services such as accepts patients for sampling, analyzes samples, provides specialists, and offers assistance. The company was founded by Valentin Furst and Astri Furst on May 4, 1950 and is headquartered in Oslo, Norway. | Amministratore Delegato | - |
Sens Utvikling AS
 Sens Utvikling AS Personnel ServicesCommercial Services Sens Utvikling AS provides labor market course services. The private company is based in Oslo, Norway. The Norwegian company was founded in 2017. The CEO is Anne Ragnhild Breiby. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Håvard Selby Ebbestad
| Società | Posizione | Fine |
|---|---|---|
| Legemiddelindustriforeningen | Presidente | 01/01/2009 |
| AstraZeneca AS | Amministratore Delegato | - |
Pfizer AS
 Pfizer AS Pharmaceuticals: MajorHealth Technology Pfizer AS operates as biopharmaceutical company, which engages in the development and manufacture of pharmaceutical products. It develops and produces medicines such as penicillin; vaccines; and medicines for the treatment of cancer, pain, cardiovascular disease, diabetes, mental illness, and rheumatism. The firm also offers drugs against parasites. The company was founded on November 25, 1959 and is headquartered in Oslo, Norway. | Amministratore Delegato | - |
| LYTIX BIOPHARMA | Direttore/Membro del Consiglio | - |
Formazione di Håvard Selby Ebbestad
| McGill University | Graduate Degree |
| University of Oslo | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Aziende private | 5 |
|---|---|
| AstraZeneca AS | |
Dr. Fürst Medisinsk Laboratorium AS
Dr. Fürst Medisinsk Laboratorium AS Medical/Nursing ServicesHealth Services Dr. Fürst Medisinsk Laboratorium AS operates as a medical laboratory in the fields of medical biochemistry, clinical pharmacology, microbiology, and pathology. The firm provides medical services such as accepts patients for sampling, analyzes samples, provides specialists, and offers assistance. The company was founded by Valentin Furst and Astri Furst on May 4, 1950 and is headquartered in Oslo, Norway. | Health Services |
Pfizer AS
Pfizer AS Pharmaceuticals: MajorHealth Technology Pfizer AS operates as biopharmaceutical company, which engages in the development and manufacture of pharmaceutical products. It develops and produces medicines such as penicillin; vaccines; and medicines for the treatment of cancer, pain, cardiovascular disease, diabetes, mental illness, and rheumatism. The firm also offers drugs against parasites. The company was founded on November 25, 1959 and is headquartered in Oslo, Norway. | Health Technology |
| Legemiddelindustriforeningen | |
Sens Utvikling AS
Sens Utvikling AS Personnel ServicesCommercial Services Sens Utvikling AS provides labor market course services. The private company is based in Oslo, Norway. The Norwegian company was founded in 2017. The CEO is Anne Ragnhild Breiby. | Commercial Services |
- Borsa valori
- Insiders
- Håvard Selby Ebbestad
